Cargando…
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm
BACKGROUND: Cytokine storm is a marker of coronavirus disease 2019 (COVID-19) illness severity and increased mortality. Immunomodulatory treatments have been repurposed to improve mortality outcomes. RESEARCH QUESTION: Do immunomodulatory therapies improve survival in patients with COVID-19 cytokine...
Autores principales: | Narain, Sonali, Stefanov, Dimitre G., Chau, Alice S., Weber, Andrew G., Marder, Galina, Kaplan, Blanka, Malhotra, Prashant, Bloom, Ona, Liu, Audrey, Lesser, Martin L., Hajizadeh, Negin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567703/ https://www.ncbi.nlm.nih.gov/pubmed/33075378 http://dx.doi.org/10.1016/j.chest.2020.09.275 |
Ejemplares similares
-
Response
por: Narain, Sonali, et al.
Publicado: (2021) -
PROTECTIVE FACTORS AGAINST THE COVID-19 STORM
por: Kang, James, et al.
Publicado: (2020) -
FERRITIN-GUIDED THERAPEUTIC PLASMA EXCHANGE (TPE) ADMINISTRATION IN COVID-19-INDUCED CYTOKINE STORM SYNDROME: A CASE SERIES
por: MASI, SEAN M, et al.
Publicado: (2022) -
COVID-19 ACE2 VS HUMAN ANGIO II: THE PERFECT STORM
por: BARNETT, S.
Publicado: (2022) -
ELDERLY PERSON WITH COVID-19 AND SEVERE ARDS WITH PROLONGED ACTIVE VIRAL REPLICATION AND DOUBLE RESURGENCE OF CYTOKINE STORM TREATED WITH SOTROVIMAB AND CASIRIVIMAB/IMDEVIMAB
por: SIRITHANAKUL, KASEM
Publicado: (2022)